Our study demonstrates that the myokine DEL-1 can attenuate ER stress-induced VEGF expression and apoptosis in hRPE cells, suggesting its potential as a therapeutic agent for AMD and eliminating the need for indirect methods such as exercise. The gene discussed is EDIL3; the disease is age-related macular degeneration.